Incorrect storage of drug; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 5-year-old female patient who received HAV (Havrix) (batch number BM4R5, expiry date APR-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number E9Y29, expiry date OCT-2024) for prophylaxis. On 10-SEP-2024, the patient received Havrix (intramuscular, right thigh) and Pediarix (intramuscular, right thigh). On an unknown date, an unknown time after receiving Havrix and Pediarix, the patient experienced incorrect storage of drug (Verbatim: Incorrect storage of drug). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 02-DEC-2024 The patient received Pediarix and Havrix vaccines after temperature excursion, which led to an incorrect storage of drug. No adverse event were reported. This was 1 of 17 linked cases, reported by same reporter.; Sender’s Comments: US2024AMR153742:Original Case : US2024AMR153742 US-GSK-US2024AMR153917:Original Case : US2024AMR153742 US-GSK-US2024AMR153918:Original Case : US2024AMR153742 US-GSK-US2024AMR153919:Original Case : US2024AMR153742 US-GSK-US2024AMR153920:Original Case : US2024AMR153742 US-GSK-US2024AMR153921:Original Case : US2024AMR153742 US-GSK-US2024AMR153929:Original Case : US2024AMR153742 US-GSK-US2024AMR153923:Original Case : US2024AMR153742 US-GSK-US2024AMR153924:Original Case : US2024AMR153742 US-GSK-US2024AMR153925:Original Case : US2024AMR153742 US-GSK-US2024AMR153926:Original Case : US2024AMR153742 US-GSK-US2024AMR153927:Original Case : US2024AMR153742 US-GSK-US2024AMR153928:Original Case : US2024AMR153742 US-GSK-US2024AMR153922:Original Case : US2024AMR153742 US-GSK-US2024123268:Same reporter US-GSK-US2024123266:Same reporter